SCHEMBL7211583

SCHEMBL7211583

CNS(=O)(=O)c1ccc(Oc2ccc3ncccc3c2)c(CN(C)C)c1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 9/20 0.60
SLC6A3 Q01959 2/20 0.59
SLC6A2 P23975 1/20 0.59
HTR2A P28223 1/20 0.47
KCNH2 Q12809 1/20 0.47
SCN9A Q15858 1/20 0.44
SOS1 Q07889 1/20 0.44
ALDH1A1 P00352 2/20 0.43
BRD4 O60885 1/20 0.42
PTGER3 P43115 1/20 0.41
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP3A4 P08684 1/20 0.40
PPARG P37231 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 1/20 0.38
AGTR1 P30556 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7211341 0.80 SLC6A4 (0.56) SLC6A4SLC6A3SLC6A2HTR2AKCNH2
SCHEMBL7065184 0.78 SLC6A4 (0.48) SLC6A4SLC6A3SLC6A2HTR2AKCNH2
SCHEMBL7065179 0.77 SLC6A4 (0.57) SLC6A4SLC6A2HTR2AKCNH2SCN9A
SCHEMBL10153946 0.77 ALDH1A1 (0.62) ALDH1A1LMNASMN1; SMN2L3MBTL1MEN1
SCHEMBL6946647 0.74 SLC6A4 (0.76) SLC6A4SLC6A3SLC6A2HTR2AKCNH2
SCHEMBL6151567 0.74 SLC6A4 (0.70) SLC6A4SLC6A3SLC6A2HTR2AKCNH2
SCHEMBL20558423 0.71 ALDH1A1 (0.61) SCN9AALDH1A1BRD4LMNASMN1; SMN2
SCHEMBL7211553 0.70 SLC6A4 (0.71) SLC6A4SLC6A3SLC6A2HTR2AKCNH2
SCHEMBL7061630 0.68 SLC6A4 (0.62) SLC6A4SLC6A3SLC6A2HTR2AKCNH2
SCHEMBL10650851 0.67 PIK3CA (0.57) ALDH1A1LMNASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6610747-B2 Such as 4-(2,3-dihydro-1-benzothien-5-yloxy)-3-((methylamino) methyl)-benzenesulfonamide for use as serotonin re-uptake inhibitors (SSRIs) in treatment of depression, attention deficit hyperactivity disorder, obsessive-compulsive disorder PFIZER INC. 2003-08-26 US disclosed